Literature DB >> 30890599

Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.

Bruno Fattizzo1,2, Austin G Kulasekararaj1, Anita Hill3, Nana Benson-Quarm1, Morag Griffin3, Talha Munir3, Louise Arnold3, Kathryn Riley3, Robin Ireland1, Hugues De Lavallade1, Victoria Potter1, Dario Consonni4, Peter Hillmen3, Ghulam J Mufti1, Wilma Barcellini2, Judith C W Marsh5.   

Abstract

Entities:  

Year:  2019        PMID： 30890599      PMCID： PMC6821617          DOI： 10.3324/haematol.2019.216374

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Guidelines for the diagnosis and management of adult aplastic anaemia.

Authors:  Sally B Killick; Nick Bown; Jamie Cavenagh; Inderjeet Dokal; Theodora Foukaneli; Anita Hill; Peter Hillmen; Robin Ireland; Austin Kulasekararaj; Ghulam Mufti; John A Snowden; Sujith Samarasinghe; Anna Wood; Judith C W Marsh
Journal:  Br J Haematol       Date:  2015-11-16       Impact factor: 6.998

2.  Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Authors:  Ronan Desmond; Danielle M Townsley; Bogdan Dumitriu; Matthew J Olnes; Phillip Scheinberg; Margaret Bevans; Ankur R Parikh; Kinneret Broder; Katherine R Calvo; Colin O Wu; Neal S Young; Cynthia E Dunbar
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

3.  Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Authors:  Danielle M Townsley; Phillip Scheinberg; Thomas Winkler; Ronan Desmond; Bogdan Dumitriu; Olga Rios; Barbara Weinstein; Janet Valdez; Jennifer Lotter; Xingmin Feng; Marie Desierto; Harshraj Leuva; Margaret Bevans; Colin Wu; Andre Larochelle; Katherine R Calvo; Cynthia E Dunbar; Neal S Young
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

4.  Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

Authors:  J Marsh; H Schrezenmeier; P Marin; O Ilhan; P Ljungman; S McCann; G Socie; A Tichelli; J Passweg; J Hows; A Raghavachar; A Locasciulli; A Bacigalupo
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

5.  Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.

Authors:  Judith C Marsh; Andrea Bacigalupo; Hubert Schrezenmeier; Andre Tichelli; Antonio M Risitano; Jakob R Passweg; Sally B Killick; Alan J Warren; Theodora Foukaneli; Mahmoud Aljurf; H A Al-Zahrani; Britta Höchsmann; Philip Schafhausen; Alexander Roth; Anke Franzke; Tim H Brummendorf; Carlo Dufour; Rosi Oneto; Philip Sedgwick; Alain Barrois; Shahram Kordasti; Modupe O Elebute; Ghulam J Mufti; Gerard Socie
Journal:  Blood       Date:  2012-04-27       Impact factor: 22.113

6.  Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Authors:  Matthew J Olnes; Phillip Scheinberg; Katherine R Calvo; Ronan Desmond; Yong Tang; Bogdan Dumitriu; Ankur R Parikh; Susan Soto; Angelique Biancotto; Xingmin Feng; Jay Lozier; Colin O Wu; Neal S Young; Cynthia E Dunbar
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

7.  Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells.

Authors:  Hong Qian; Natalija Buza-Vidas; Craig D Hyland; Christina T Jensen; Jennifer Antonchuk; Robert Månsson; Lina A Thoren; Marja Ekblom; Warren S Alexander; Sten Eirik W Jacobsen
Journal:  Cell Stem Cell       Date:  2007-11-20       Impact factor: 24.633

8.  Age and Bone Marrow Cellularity are Associated with Response to Eltrombopag in Japanese Adult Immune Thrombocytopenia Patients: A Retrospective Single-Center Study.

Authors:  Yui Uto; Shun Fujiwara; Nana Arai; Yukiko Kawaguchi; Nobuyuki Kabasawa; Hiroyuki Tsukamoto; Hirotsugu Ariizumi; Norimichi Hattori; Bungo Saito; Kouji Yanagisawa; Hiroshi Harada; Hiraku Mori; Eisuke Shiozawa; Tsuyoshi Nakamaki
Journal:  Rinsho Byori       Date:  2015-05

9.  Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.

Authors:  Etienne Lengline; Bernard Drenou; Pierre Peterlin; Olivier Tournilhac; Julie Abraham; Ana Berceanu; Brigitte Dupriez; Gaelle Guillerm; Emmanuel Raffoux; Flore Sicre de Fontbrune; Lionel Ades; Marie Balsat; Driss Chaoui; Paul Coppo; Selim Corm; Thierry Leblanc; Natacha Maillard; Louis Terriou; Gerard Socié; Regis Peffault de Latour
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

10.  Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.

Authors:  Krista Vaht; Magnus Göransson; Kristina Carlson; Cecilia Isaksson; Stig Lenhoff; Anna Sandstedt; Bertil Uggla; Jacek Winiarski; Per Ljungman; Mats Brune; Per-Ola Andersson
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941
View more
  8 in total

1.  Paroxysmal nocturnal hemoglobinuria-phenotype cells predict a good response to eltrombopag in patients with refractory aplastic anemia.

Authors:  Ken Ishiyama; Keijiro Sato; Tatsuya Imi; Kohei Hosokawa; Yukio Kondo; Naomi Sugimori; Hirohito Yamazaki; Shinji Nakao
Journal:  EJHaem       Date:  2020-06-29

2.  Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.

Authors:  Wenrui Yang; Xin Zhao; Guangxin Peng; Li Zhang; Liping Jing; Kang Zhou; Yang Li; Lei Ye; Yuan Li; Jianping Li; Huihui Fan; Yang Yang; Fengkui Zhang
Journal:  Ann Hematol       Date:  2021-07-16       Impact factor: 3.673

3.  Exosomes derived from mesenchymal stem cells regulate Treg/Th17 balance in aplastic anemia by transferring miR-23a-3p.

Authors:  Qing-Zhao Shi; Hong-Mei Yu; Hong-Mei Chen; Miao Liu; Xue Cheng
Journal:  Clin Exp Med       Date:  2021-03-29       Impact factor: 3.984

4.  Correlation of the Plasma Concentration of Eltrombopag With Efficacy in the Treatment of Refractory Aplastic Anemia: A Single-Centre Study in China.

Authors:  Wei Zuo; Bo Zhang; Jing Ruan; Miao Chen; Bing Han
Journal:  Front Pharmacol       Date:  2020-11-16       Impact factor: 5.810

5.  Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.

Authors:  Ruixin Li; Jiongtao Zhou; Zhengyuan Liu; Xi Chen; Qiqiang Long; Yan Yang; Shengyun Lin; Jinsong Jia; Guangsheng He; JianYong Li
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 6.  Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow.

Authors:  Antonio G Solimando; Carmen Palumbo; Mary Victoria Pragnell; Max Bittrich; Antonella Argentiero; Markus Krebs
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

7.  Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias.

Authors:  Xing Fan; Ronan Desmond; Thomas Winkler; David J Young; Bogdan Dumitriu; Danielle M Townsley; Fernanda Gutierrez-Rodrigues; Jennifer Lotter; Janet Valdez; Stephanie E Sellers; Ma Evette Barranta; Ruba N Shalhoub; Colin O Wu; Maher Albitar; Katherine R Calvo; Neal S Young; Cynthia E Dunbar
Journal:  Blood Adv       Date:  2020-04-28

Review 8.  Novel therapeutic choices in immune aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  F1000Res       Date:  2020-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.